GGrantIndex
← Search

DEVELOPMENT OF A PROPHYLACTIC ONCHOCERCIASIS VACCINE

$441,905N43FY2016AINIH

Pai Life Sciences, Inc., Seattle WA

Investigators

Abstract

To develop an onchocerciasis vaccine to be used for disease control and elimination.

View original record on NIH RePORTER →